One day, will you see drugs for the female libido advertised as heavily as Viagra? It’s possible.
The drug flibanserin was created as an antidepressant, but it doesn’t work so well for depression. However, the pooled results from three separate clinical trials revealed that the drug successfully treats women with low libido. But don’t ask your doc about it just yet. Right now, flibanserin is just an investigational drug for women in clinical trials.

In the studies, women with hypoactive sexual desire disorder reported significant improvements in sexual desire and satisfactory sexual experiences while taking flibanserin. “It’s essentially a Viagra-like drug for …read more

Cymbalta (duloxetine) is an antidepressant medication that has also been found to help manage some types of chronic pain, such as the nerve pain from diabetic neuropathy. This isn’t to infer that the chronic pain is in your mind, not at all. What has happened is that the actions of Cymbalta not only are on what causes depression, but may work on what causes chronic pain.
People who live with chronic lower back pain understand all too well what it’s like not to be believed half the time and not to be able to control the pain much of the time. …read more

And in fact, they can be downright dangerous!
Bipolar II, also known as manic depression, is a disorder characterized by mood swings from elevated or manic phases to depressed phases. Unlike its more severe form, bipolar I, bipolar II is not characterized by hallucinations and delusions. Frequently misdiagnosed and mistreated as suffering from depression alone or depression and ADHD (yup, that was me until I got the right doctor!), bipolar II sufferers often benefit more from the addition or substitution of mood stabilizers in their treatment regime.
In the past, antidepressants have ironically been associated with suicidal behaviors, but it …read more

A new study indicates that daily use of selective serotonin reuptake inhibitors (SSRIs), a common class of antidepressant, may increase the risk of fracture in people over 50.
“Other studies have pointed to this [link], but our study confirms it,” says David Goltzman, MD, one of the study’s authors. Goltzman is director of the Centre for Bone and Periodontal Research at McGill University in Montreal.